BAX Baxter International Inc.
2,348
$35.39
$0.15
(0.43%)
| Watchers | 2,348 |
| 52-Wk Low | $31.01 |
| 52-Wk High | $50.21 |
| Market Cap | $18.05B |
| Volume | 2.53M |
| 52-Wk High | $50.21 |
| 52-Wk Low | $31.01 |
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric IndicationBusiness Wire • 2 days ago
Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in...
Share to Feed
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America 2024 Health Care Conference on Wednesday, May 15, 2024. Joel Grade, Baxters chief financial officer...
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is...
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024. Baxters results in the first quarter reflect the companys solid operational...
Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product...
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To...
Baxter International (NYSE:BAX - Free Report) had its price target lifted by Citigroup from $41.00 to $44.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Humana (HUM Research Report), Baxter International...
Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large...
Home Federal Bank of Tennessee raised its stake in shares of Baxter International Inc. (NYSE:BAX - Free Report) by 23.7% during the fourth quarter, according to the company in its most recent Form...